ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 209,28
-0,12%
Dow Jones
39 431,51
-0,21%
DAX
18 742,22
-0,08%
Brent Oil
83,21
1,00%
Bitcoin
62 752,39
2,12%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Biotie Therapies Corp. (MM) (BITI)

  7. Biotie Therapies Corp. (MM) (BITI) Actualités

BITI

BIOTIE THERAPIES CORP. (BITI)

Biotie Therapies Corp. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BITI
DateHeureSourceTitreSymboleSociété
13/06/201622h56Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BITIBiotie Therapies Corp. (MM)
13/06/201615h30Business WireBiotie Therapies Corp. Announces That the Delisting of Its American Depositary Shares from NASDAQ Global Select Market Has Be...NASDAQ:BITIBiotie Therapies Corp. (MM)
02/06/201622h54Edgar (US Regulatory)(25)NASDAQ:BITIBiotie Therapies Corp. (MM)
04/05/201612h07Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:BITIBiotie Therapies Corp. (MM)
04/05/201612h03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BITIBiotie Therapies Corp. (MM)
02/05/201622h48Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:BITIBiotie Therapies Corp. (MM)
02/05/201615h02Business WireFinal Results of the Subsequent Offer Period of Acorda Therapeutics' Tender Offer for All of the Shares, American Depositary ...NASDAQ:BITIBiotie Therapies Corp. (MM)
25/04/201622h37Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:BITIBiotie Therapies Corp. (MM)
18/04/201622h01Business WireCompletion of Acorda Therapeutics' Voluntary Tender Offer for All of the Issued & Outstanding Shares, American Depositary Sha...NASDAQ:BITIBiotie Therapies Corp. (MM)
15/04/201612h06Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BITIBiotie Therapies Corp. (MM)
13/04/201615h00Business WireFinal Results of Acorda Therapeutics' Voluntary Tender Offer for All of the Issued & Outstanding Shares, American Depositary ...NASDAQ:BITIBiotie Therapies Corp. (MM)
11/04/201614h59Business WireAcorda Therapeutics Announces Preliminary Tender Offer Results & Acceptance of the Shares, American Depositary Shares, Stock ...NASDAQ:BITIBiotie Therapies Corp. (MM)
22/03/201622h13Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:BITIBiotie Therapies Corp. (MM)
22/03/201613h03Business WireAcorda Therapeutics Supplements the Tender Offer Document Relating to the Voluntary Public Tender Offer for All of the Issued...NASDAQ:BITIBiotie Therapies Corp. (MM)
18/03/201614h03Business WireAcorda Therapeutics Supplements Tender Offer Document Relating to the Voluntary Public Tender Offer for All of the Issued & O...NASDAQ:BITIBiotie Therapies Corp. (MM)
11/03/201612h20Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:BITIBiotie Therapies Corp. (MM)
11/03/201612h12Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:BITIBiotie Therapies Corp. (MM)
10/03/201618h06Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:BITIBiotie Therapies Corp. (MM)
10/03/201614h40Business WireAcorda Therapeutics, Inc. Will Commence the Voluntary Public Tender Offer for All of the Issued & Outstanding Shares, America...NASDAQ:BITIBiotie Therapies Corp. (MM)
03/03/201622h53Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:BITIBiotie Therapies Corp. (MM)
03/03/201607h30Business WireAcorda Has Filed Tender Offer Document Relating to Public Tender Offer For Biotie Therapies with Finnish Financial Supervisor...NASDAQ:BITIBiotie Therapies Corp. (MM)
17/02/201607h30Business WireAcorda Announces Expiration of the Hart-Scott-Rodino Waiting Period for Its Tender Offer for Biotie TherapiesNASDAQ:BITIBiotie Therapies Corp. (MM)
16/02/201612h09Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BITIBiotie Therapies Corp. (MM)
19/01/201609h09Business WireAcorda Announces a Recommended Cash Tender Offer for All Shares, ADSs and Other Equity Instruments in BiotieNASDAQ:BITIBiotie Therapies Corp. (MM)
19/01/201608h50Business WireAcorda to Acquire Biotie TherapiesNASDAQ:BITIBiotie Therapies Corp. (MM)
20/08/201522h37Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BITIBiotie Therapies Corp. (MM)
12/06/201517h33Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:BITIBiotie Therapies Corp. (MM)
11/06/201523h07Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:BITIBiotie Therapies Corp. (MM)
11/06/201512h08Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:BITIBiotie Therapies Corp. (MM)
11/06/201512h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BITIBiotie Therapies Corp. (MM)
 Showing the most relevant articles for your search:NASDAQ:BITI

Dernières Valeurs Consultées

EU
BNP
BNP Paribas
EU
VK
Vallourec
NYSE
NKE
Nike
EU
MC
Lvmh Moet Hennessy Louis...
EU
RNO
Renault
EU
CAP
Capgemini
NASDAQ
MSFT
Microsoft
EU
LR
Legrand
FTSE
UKX
FTSE 100
NASDAQ
GOOGL
Alphabet
NASDAQ
AMZN
Amazon.com
COIN
ETHUSD
Ethereum
EU
AF
Air FranceKLM
COIN
BTCUSD
Bitcoin
EU
RI
Pernod Ricard
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés